Mid career · publishing since 2014Rising activity
HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchRadiopharmaceutical Chemistry and ApplicationsCAR-T cell therapy researchCell Adhesion Molecules Research
Publications
37
Citations
687
Est. group size
~1
Recurring co-author estimate
Active years
13
Publishing since 2014
In context
Among 4,491 mid career Medicine PIs within our index
Citations: 687p25 240 · p75 1,552 · cohort median 614
Publications / year (recent): 3.6p25 1.8 · p75 7.2 · cohort median 3.4
Typically publishes in teams of ~7 · 33% small-team papers (≤3 authors) · across 2 venues
Publication cadence
Publications per year over the last 10 years — averaging 3.6/year recently
Recent publications
- Model-informed scheduling of drug combinations for optimal treatment of cancer: a case study of JDQ443 and TNO155 dose regimen optimization
2026
- Foundational Principles for the Quantitative Translation of T‐Cell Therapeutics for Hematologic Malignancies and Immunology
Clinical Pharmacology & Therapeutics · 2025
- Engineering Tumor Distribution of Antibody-Drug Conjugates
Deep Blue (University of Michigan) · 2021
Publishes in
- Journal of Nuclear Medicine×2
- Journal of Visualized Experiments×2
- Chemical Engineering Education×2
- Cancer Research×1
- BioDrugs×1
Similar researchers
By research-topic overlap
- Brandon M. Bordeau
Medicine · University of Michigan
- Jiashuai Zhang
Medicine · The Ohio State University
- Dong Jun Koo
Medicine · University of Michigan
- Daniel C. Koboldt
Medicine · The Ohio State University
- Keith Miller
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile